COMMUNIQUÉS West-GlobeNewswire

Opiant Pharmaceuticals Announces Publication of Clinical Pharmacokinetic Data Supporting Potential of OPNT002, Nasal Naltrexone, for Treatment of Alcohol Use Disorder
03/04/2019
Data published online in The Journal of Clinical Pharmacology SANTA MONICA, Calif., April 03, 2019 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT), a specialty pharmaceutical company developing medicines [...]
Shockwave Completes Enrollment of Disrupt CAD II Study
03/04/2019
European Post-Market Study to Demonstrate Ongoing Safety of Coronary Intravascular Lithotripsy SANTA CLARA, Calif., April 03, 2019 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development [...]
Catalyst Biosciences to Present at The Needham & Company 18th Annual Healthcare Conference
03/04/2019
SOUTH SAN FRANCISCO, Calif., April 03, 2019 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ:CBIO), today announced that Nassim Usman, Ph.D., president and chief executive officer, will present a corporate [...]
Join Achieve TMS East to Celebrate the Grand Opening of its Woburn Location
03/04/2019
WOBURN, Mass., April 03, 2019 (GLOBE NEWSWIRE) -- Achieve TMS East , Massachusetts’ largest provider of Deep Transcranial Magnetic Stimulation (Deep TMS) therapy for the treatment of depression and Obsessive-Compulsive [...]
TYME Secures Capital to Advance Pivotal Studies of SM-88 in Metastatic Pancreatic Cancer
03/04/2019
Announces Closing of Registered Offering NEW YORK, April 03, 2019 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME) , an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs TM ), [...]
Cutting-Edge HeartCare and AlloMap Solutions Featured at ISHLT 2019
03/04/2019
CareDx commitment to transplant innovation highlighted through seven podium and poster presentations BRISBANE, Calif., April 03, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading molecular diagnostics [...]
Nu-Med Plus Reports Spike in International Interest from Physicians, Distributors, and Potential Strategic Partners
03/04/2019
Global health implications of Nu-Med Plus’ technology fuels new overseas inquiries to potentially treat conditions including malaria, tuberculosis, COPD and neonatal respiratory issues SALT LAKE CITY, April 03, 2019 ( [...]
VBI Vaccines Announces Poster Presentation at the 7th International Congenital CMV Conference & 17th International CMV Workshop
03/04/2019
CAMBRIDGE, Mass., April 03, 2019 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (NASDAQ: VBIV) (“VBI”), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, [...]
Fibrocell Announces Board Member Christine St.Clare Honored by National Association of Corporate Directors
03/04/2019
- Annual NACD Directorship 100 List Recognizes the Most Influential Corporate Governance Experts - EXTON, Pa., April 03, 2019 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (Nasdaq: FCSC), a gene therapy company focused on [...]
Tabula Rasa HealthCare Participates in NPA’s Spring Policy Forum
03/04/2019
Hosts Reception, Exhibits Technology and Services, and Introduces New Product for PACE MOORESTOWN, N.J., April 03, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC) , a healthcare technology [...]
Bio-Path Holdings Presents Preclinical Data at American Association for Cancer Research Annual Meeting 2019
03/04/2019
Highlighting Important Cancer Gene, STAT3, Therapeutic Strategy in Pancreatic, Non-Small Cell Lung Cancers and Acute Myelogenous Leukemia HOUSTON, April 03, 2019 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: [...]
Precipio’s HemeScreen™ Adopted by Methodist Health
03/04/2019
New Molecular Screening Assay Technology Gains Traction NEW HAVEN, Conn., April 03, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), announced today that Methodist Hospital , [...]
Genmab Announces Phase III Study Exploring Daratumumab as Maintenance Treatment in Newly Diagnosed Multiple Myeloma
03/04/2019
Company Announcement Phase III study to examine daratumumab plus lenalidomide as maintenance treatment in patients with newly diagnosed multiple myeloma Study utilizes the subcutaneous formulation of daratumumab Study [...]
RTI Surgical® Showcases Novel Spine Portfolio at ISASS19
03/04/2019
RTI to host Lunch Workshop as the Platinum Partner at ISASS19 and highlight recent additions to its Spine portfolio, including the coflex® Interlaminar Stabilization® device DEERFIELD, Ill., April 03, 2019 (GLOBE [...]
T2 Biosystems to Present at the 18th Annual Needham Healthcare Conference
03/04/2019
LEXINGTON, Mass., April 03, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare [...]
Metacrine to Present Phase 1 Results of MET409, an Optimized Next Generation FXR Agonist at The International Liver Congress (EASL) 2019
03/04/2019
SAN DIEGO, April 03, 2019 (GLOBE NEWSWIRE) -- Metacrine, Inc., a clinical-stage biotechnology company focused on building an innovative pipeline of best-in-class drugs to treat liver and gastrointestinal (GI) diseases, [...]
Data in Parkinson’s Disease Model in Non-human Primates Demonstrate Reversal of Cognitive Deficits with Novel NMDA Receptor Modulator, NYX-458
03/04/2019
EVANSTON, Ill., April 03, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (NASDAQ: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, [...]
Summit’s Pipeline Expands with Series of New Mechanism Antibiotics Targeting Enterobacteriaceae
03/04/2019
Summit Therapeutics plc (‘Summit’ or the ’Company’) Summit’s Pipeline Expands with Series of New Mechanism Antibiotics Targeting Enterobacteriaceae Data to be Presented in Oral Session at ECCMID 2019 Oxford, UK, and [...]
XOMA to Present at the 2019 H.C. Wainwright Global Life Sciences Conference
03/04/2019
EMERYVILLE, Calif., April 03, 2019 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) announced today its Chief Executive Officer, Jim Neal, will present an update about the company’s business at the 2019 H.C. [...]

Pages